Johnson & Johnson stock rises as JNJ gets fresh price-target bump — what investors watch next
Shares of Johnson & Johnson climbed 1.7% to $225.19 Tuesday afternoon, outpacing the wider healthcare sector. The gain came after analysts raised their price targets in response to the company’s latest earnings report and its outlook for 2026. https://www.reuters.com/markets/companies/JNJ.N/
